The global epigenetics market size is expected to reach USD 39.15 billion by 2030, registering a CAGR of 15.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is being driven by factors, such as the rise in funding, investment & regulatory approvals for epigenetics research & development, the expansion of the use of epigenetic enzymes in drug discovery & development, and the decreasing cost of genome sequencing. Since epigenetics has demonstrated beneficial applications outside of cancer, commercial expansion is envisaged.The rising demand for understanding epigenetic alterations at the molecular level, as well as the advancement of medicinal treatments, would likely push these organizations to support research and development programs.
Furthermore, initiatives, such as the Epidemiology and Genomics Research Program (EGRP), provide incentives for research efforts aimed at better-comprehending cancer genesis and consequences.A few organizations that help fuel the market's rise are the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institutes of Health (NIH). These organizations support funding and help for initiatives involving product development and R&D in the field of epigenetics. For instance, the National Institutes of Health aggressively promotes cutting-edge epigenetic research worldwide through its common fund epigenomics program.
Request a free sample copy or view report summary: Epigenetics Market Report
Epigenetics Market Report Highlights
By product, the reagents segment dominated the industry, accounting for 33.45% of the global revenue in 2023. The large share of this segment can be attributed to the high usage of reagents in epigenetic research studies.
By technology, the DNA methylation segment dominated the market with a revenue share of 45.36% in 2023. DNA methylation's demand in epigenetics stems from its pivotal role in gene expression regulation.
By application, the oncology segment dominated the market with a revenue share of 69.06% in 2023. Oncology's demand for epigenetics arises from the intricate relationship between epigenetic alterations and cancer development.
North America dominated the market and accounted for a 38.19% share in 2023. The region experiences growth due to heightened public awareness, robust medical facilities, and substantial R&D investments.
Epigenetics Market Segmentation
Grand View Research has segmented the global epigenetics market on the basis of product, technology, application, end-use, and region:
Epigenetics Product Outlook (Revenue, USD Million, 2018 - 2030)
Reagents
Kits
ChIP sequencing kit
Whole Genomic Amplification kit
Bisulfite Conversion kit
RNA sequencing kit
Others
Instruments
Enzymes
Services
Epigenetics Technology Outlook (Revenue, USD Million, 2018 - 2030)
DNA Methylation
Histone Methylation
Histone Acetylation
Large non-coding RNA
MicroRNA modification
Chromatin structures
Epigenetics Application Outlook (Revenue, USD Million, 2018 - 2030)
Oncology
Solid tumors
Liquid tumors
Non-oncology oncology
Inflammatory diseases
Metabolic diseases
Infectious diseases
Cardiovascular diseases
Others
Epigenetics End-use Outlook (Revenue, USD Million, 2018 - 2030)
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other Users
Epigenetics Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Epigenetics Market
Roche Diagnostics
Thermo Fisher Scientific, Inc.
Eisai Co. Ltd.
Novartis AG
Element Biosciences, Inc.
Dovetail Genomics LLC.
Illumina, Inc.
Promega Corporation.
Abcam plc.
Explore Horizon, the world’s most expansive market research database
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Sign in to leave a comment.